Abbonarsi

Esmolol, vector change, and dose-capped epinephrine for prehospital ventricular fibrillation or pulseless ventricular tachycardia - 13/01/23

Doi : 10.1016/j.ajem.2022.11.019 
Kyle Stupca, PharmD a, , Nicholas Scaturo, PharmD a, Eileen Shomo, PharmD a, Tonya King, PhD b, Marshall Frank, DO, MPH c, d
a Department of Pharmaceutical Care Services, Sarasota Memorial Hospital, 1700 S Tamiami Trl, Sarasota, FL 34239, USA 
b Research Institute, Sarasota Memorial Hospital, 1700 S Tamiami Trl, Sarasota, FL 34239, USA 
c Emergency Medicine Program, Florida State University, Sarasota Memorial Hospital, 1700 S Tamiami Trl, Sarasota, FL 34239, USA 
d Sarasota County Fire Department, 1660 Ringling Blvd, Sarasota, FL 34236, USA 

Corresponding author.

Abstract

Background

Refractory ventricular fibrillation (VF) and pulseless ventricular tachycardia (pVT) cardiac arrest describes a subset of patients who do not respond to standard Advanced Cardiac Life Support (ACLS) interventions and are associated with poor outcomes. Esmolol administration and vector change defibrillation have shown promise in improving outcomes in these patients, however evidence is limited.

Objectives

This study compares clinical outcomes between patients with prehospital refractory VF/pVT who received an Emergency Medical Service (EMS) bundle, comprised of esmolol administration, vector change defibrillation, and dose-capped epinephrine at 3 mg, to patients who received standard ACLS interventions.

Methods

This multicenter, retrospective, cohort study evaluated medical records between October 18, 2017 and March 15, 2022. Patients were enrolled if they experienced a prehospital cardiac arrest with the rhythm VF or pVT, had received at least three standard defibrillations, at least 3 mg of epinephrine, and 300 mg of amiodarone. Patients who received the EMS bundle after its implementation were compared to patients who received standard ACLS interventions prior to its implementation. The primary outcome was sustained return of spontaneous circulation (ROSC), defined as ROSC lasting 20 min without recurrence of cardiac arrest. Secondary outcomes included the incidence of any ROSC, survival to hospital arrival, survival at hospital discharge, and neurologically intact survival at hospital discharge.

Results

Eighty-three patients were included in the study. Thirty-six were included in the pre-EMS bundle group and 47 patients were included in the post-EMS bundle group. Patients in the pre-EMS bundle group achieved significantly higher rates of sustained ROSC (58.3% vs 17%, p < 0.001), any ROSC (66.7% vs 19.1%, p < 0.001), and survival to hospital arrival (55.6% vs 17%, p < 0.001). The rates of survival to hospital discharge (16.7% vs 6.4%, p = 0.17) and neurologically intact survival at hospital discharge (5.9% vs 4.3%, p = 1.00) were not significantly different between groups.

Conclusions

Patients who received the EMS bundle achieved sustained ROSC significantly less often and were less likely to have pulses at hospital arrival. The incidence of neurologically intact survival was low and similar between groups.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Cardiac arrest, Refractory ventricular fibrillation, Esmolol, Vector change, Defibrillation, Cardiopulmonary resuscitation


Mappa


© 2022  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 64

P. 46-50 - febbraio 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • ICD-10-CM codes infrequently used to document human trafficking in 2019 Nationwide Emergency Department Sample
  • Nathaniel Dell, Erica Koegler, Katherine J. Holzer, Michael G. Vaughn, Cindy Bitter, Rumi Kato Price
| Articolo seguente Articolo seguente
  • Performance analysis considering endpoints for three accelerated diagnostic protocols for chest pain
  • Bora Chae, Shin Ahn, Seung Mok Ryoo, Youn-Jung Kim, Dong-Woo Seo, Chang Hwan Sohn, Won Young Kim

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.